×

Register now for full access to all the content

First Name
Last Name
Company
Title
Country
Thank you for registering!
Error - something went wrong!

Alberto Grignolo, PhD Speaks on Regulatory Landscape in Japan Over the Next 5 Years

November 21, 2012
Alberto Grignolo, PhD speaks on the regulatory landscape in Japan over the next 5 years. He talks about the positive trends in having Japan participate in the globalization of drug development. Alberto also covers the recent changes announced by the PMDA that could end the development lag paving the way for patients to gain faster access to new and innovative medicines.
Previous Video
Joshua Schultz, VP Speaks on Adding Value Through Strategic Partnerships
Joshua Schultz, VP Speaks on Adding Value Through Strategic Partnerships

Josh talks about the value of strategic partnerships between biopharmaceutical companies and PAREXEL. He go...

Next Video
China's Role as a Development Hotspot for Biopharmaceutical Companies
China's Role as a Development Hotspot for Biopharmaceutical Companies

Dr. Karen Chu, Corporate VP of Project Leadership Asia Pacific, PAREXEL explains China's role as a developm...